Publications by authors named "Raquel Castejon-Diaz"
Interactions between anti-hypertensive agents (ACEI), comorbidities, inflammation, and stress status may impact hospital stay duration in COVID-19 patients. This retrospective study analyzed epidemiological data, comorbidities, metabolic/inflammatory markers, and clinical information from 165 SARS-CoV-2 positive patients. In a multiple linear regression model, an IL-6 higher than 100 mg/L, glucose at admission (baseline levels at the hospital entry), and the interaction between ACEI administration and LDH predicted the days of hospital admission (P < 0.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 manifests through various symptoms affecting respiratory, gastrointestinal, and other systems, with links to obesity, diabetes, and cardiovascular issues exacerbating the condition.
- This study analyzed 165 patients diagnosed with COVID-19 pneumonia to assess their metabolic status and predict health outcomes, noting common comorbidities like hypertension, dyslipidemia, obesity, and diabetes.
- Findings indicate that obesity significantly increases the risk of ICU admission and longer hospital stays, highlighting associations between body mass index, blood glucose levels, and mortality rates during hospitalization.